+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East Stem Cell Market Size, Share & Trends Analysis Report by Product (Adult Stem Cells, Human Embryonic Stem Cells), Application, Technology, Therapy, End-use, Country, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 90 Pages
  • March 2024
  • Region: Middle East
  • Grand View Research
  • ID: 5950075
Description Jump to:
The Middle East stem cell market size is anticipated to reach USD 1.14 billion by 2030, growing at a CAGR of 7.56% during the forecast period. The rising prevalence of chronic diseases such as cancer and diabetes, rising awareness about the benefits of stem cell therapies, favorable government initiatives and investments, and a growing demand for regenerative medicine. The advancements in stem cell research and technology are also expected to drive the market growth. For instance, in September 2023, Abu Dhabi Stem Cells Center, a subsidiary of PureHealth manufactured UAE's inaugural CAR-T cells for treating leukemia in an 11-year-old boy. The development of engineered CAR-T cell therapies signifies an advancement in the treatment of blood cancers.

Collaboration initiatives drive the major Middle East stem cell market by fostering knowledge sharing, interdisciplinary collaboration, access to resources, capacity building, commercialization, and international networking. By leveraging collaborative approaches, stakeholders in the Middle East can accelerate progress in stem cell research and therapy and position the region as a hub for innovation in regenerative medicine. For instance, in August 2020, In order to develop stem cell therapies for COVID-19, Pluristem (Haifa, Israel) collaborated with Abu Dhabi Stem Cells Center (UAE). The collaboration fosters knowledge sharing and scientific exchange between Israel and the UAE, contributing to advancements in the field of stem cells.

COVID-19 has led to various challenges and opportunities, reshaping the landscape of stem cell research and therapy in the region. Initially, the outbreak caused disruptions in stem cell research activities, with laboratories closing or operating at reduced capacity due to lockdowns and safety measures. Clinical trials involving stem cell therapies faced delays or suspensions, affecting the progression of research projects. However, the pandemic also highlighted the importance of stem cell therapies in addressing critical health challenges. Researchers and clinicians redirected their efforts toward exploring the potential of stem cells in combating COVID-19 and its complications. Stem cell-based treatments, such as mesenchymal stem cell therapy, emerged as potential interventions for mitigating severe symptoms and promoting recovery in COVID-19 patients.

The lack of a comprehensive and harmonized regulatory framework for stem cell research and therapy in Middle East poses a significant challenge. Varied regulations and ethical considerations in different countries within the region create complexities for researchers, clinicians, and industry stakeholders. There needs to be more widespread understanding and awareness about stem cell research and its potential applications among the public in the Middle East. Misconceptions and ethical concerns surrounding stem cell therapy may hinder acceptance and adoption, leading to reluctance from patients and healthcare providers. Stem cell research and therapy need more infrastructure and expertise to advance scientific discoveries and translate them into clinical applications. The availability of state-of-the-art facilities, skilled personnel, and collaborations with international experts are crucial for fostering innovation in the field.

Middle East Stem Cell Market Report Highlights

  • Adult Stem Cells (ASCs) dominated the product segment with 81.65% share in 2023 owing to the increasing prevalence of chronic diseases in adults
  • The regenerative medicine application segment held the larger market share in 2023. On the other hand, the drug discovery and development segment is expected to grow at a higher CAGR during the forecast period.
  • In 2023, cell acquisition dominated the technology segment and Cell production is expected to at the significant CAGR over the forecast period
  • In 2023, allogenic dominated the therapy segment and autologous are expected to at the significant CAGR from 2024 to 2030
  • Pharmaceutical and biotechnology companies dominated the end-user segment with the largest share in 2023.
  • Saudi Arabia dominated the stem cell market in Middle East with a share of 41.96% owing to factors such as the high purchasing power parity, government support for quality healthcare, and availability of reimbursement.


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Technology
1.2.4. Therapy
1.2.5. End-user
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Funds for Accelerating Stem Cell Research
3.2.1.2. Growing Demand for Stem Cell Banking
3.2.1.3. Increasing Prevalence of Genetic Disorders
3.2.2. Market Restraint Analysis
3.2.2.1. Ethical Concern Related to Stem Cell Research
3.2.2.2. Lack of a Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Middle East Stem Cell Market: Product Business Analysis
4.1. Segment Dashboard
4.2. Middle East Stem Cell Market Product Movement Analysis
4.3. Middle East Stem Cell Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Adult Stem Cells (ASCs)
4.4.1. Middle East Adult Stem Cells (ASCs) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Hematopoietic
4.4.2.1. Middle East Hematopoietic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Mesenchymal
4.4.3.1. Middle East Mesenchymal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Neural
4.4.4.1. Middle East Neural Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Epithelial/Skin
4.4.5.1. Middle East Epithelial/Skin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. Others
4.4.6.1. Middle East Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Human Embryonic Stem Cells (HESCs)
4.5.1. Middle East Human Embryonic Stem Cells (HESCs) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Induced Pluripotent Stem Cells (iPSCs)
4.6.1. Middle East-Induced Pluripotent Stem Cells (iPSCs) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Very Small Embryonic Like Stem Cells
4.7.1. Middle East Very Small Embryonic Like Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Middle East Stem Cell Market: Application Business Analysis
5.1. Segment Dashboard
5.2. Middle East Stem Cell Market Application Movement Analysis
5.3. Middle East Stem Cell Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Regenerative Medicine
5.4.1. Middle East Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Neurology
5.4.2.1. Middle East Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Orthopedics
5.4.3.1. Middle East Orthopedics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Oncology
5.4.4.1. Middle East Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Hematology
5.4.5.1. Middle East Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Cardiovascular and Myocardial Infraction
5.4.6.1. Middle East Cardiovascular and Myocardial Infraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Injuries
5.4.7.1. Middle East Injuries Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.8. Diabetes
5.4.8.1. Middle East Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.9. Liver Disorder
5.4.9.1. Middle East Liver Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.10. Incontinence
5.4.10.1. Middle East Incontinence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.11. Others
5.4.11.1. Middle East Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Drug Discovery and Development
5.5.1. Middle East Drug Discovery and Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Middle East Stem Cell Market: Technology Business Analysis
6.1. Segment Dashboard
6.2. Middle East Stem Cell Market Technology Movement Analysis
6.3. Middle East Stem Cell Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
6.4. Cell Acquisition
6.4.1. Middle East Cell Acquisition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Bone Marrow Harvest
6.4.2.1. Middle East Bone Marrow Harvest Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Umbilical Blood Cord
6.4.3.1. Middle East Umbilical Blood Cord Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Apheresis
6.4.4.1. Middle East Apheresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cell Production
6.5.1. Middle East Cell Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Therapeutic Cloning
6.5.2.1. Middle East Therapeutic Cloning Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. In-vitro Fertilization
6.5.3.1. Middle East In-vitro Fertilization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Cell Culture
6.5.4.1. Middle East Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Isolation
6.5.5.1. Middle East Isolation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cryopreservation
6.6.1. Middle East Cryopreservation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Expansion and Sub-Culture
6.7.1. Middle East Expansion and Sub-Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Middle East Stem Cell Market: Therapy Business Analysis
7.1. Segment Dashboard
7.2. Middle East Stem Cell Market Therapy Movement Analysis
7.3. Middle East Stem Cell Market Size & Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
7.4. Autologous
7.4.1. Middle East Autologous Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Allogenic
7.5.1. Middle East Allogenic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Middle East Stem Cell Market: End-user Business Analysis
8.1. Segment Dashboard
8.2. Middle East Stem Cell Market End-user Movement Analysis
8.3. Middle East Stem Cell Market Size & Trend Analysis, by End-user, 2018 to 2030 (USD Million)
8.4. Pharmaceutical and Biotechnology Companies
8.4.1. Middle East Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Hospitals & Cell Banks
8.5.1. Middle East Hospitals & Cell Banks Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Academic & Research Institutes
8.6.1. Middle East Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Middle East Stem Cell Market: Country Estimates & Trend Analysis by Product, Application, Technology, Therapy, & End-user
9.1. Country Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. Saudi Arabia
9.3.1. Key Country Dynamics
9.3.2. Competitive Scenario
9.3.3. Regulatory Framework
9.3.4. Saudi Arabia Stem Cell Market, 2018 - 2030 (USD Million)
9.4. UAE
9.4.1. Key Country Dynamics
9.4.2. Competitive Scenario
9.4.3. Regulatory Framework
9.4.4. UAE Stem Cell Market, 2018 - 2030 (USD Million)
9.5. Kuwait
9.5.1. Key Country Dynamics
9.5.2. Competitive Scenario
9.5.3. Regulatory Framework
9.5.4. Kuwait Stem Cell Market, 2018 - 2030 (USD Million)
9.6. Israel
9.6.1. Key Country Dynamics
9.6.2. Competitive Scenario
9.6.3. Regulatory Framework
9.6.4. Israel Stem Cell Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Participant’s Overview
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. STEMCELL Technologies Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Merck KGaA
10.4.3.1. Overview
10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. CellGenix GmbH
10.4.4.1. Overview
10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. Takara Bio
10.4.5.1. Overview
10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Lonza
10.4.6.1. Overview
10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Cellartis AB
10.4.7.1. Overview
10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. ATCC
10.4.8.1. Overview
10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. AcceGen
10.4.9.1. Overview
10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Cell Applications, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
10.4.11. Bio-Techne
10.4.11.1. Overview
10.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.11.3. Product Benchmarking
10.4.11.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East stem cell market, by product, 2018 - 2030 (USD Million)
Table 4 Middle East stem cell market, by application, 2018 - 2030 (USD Million)
Table 5 Middle East stem cell market, by technology, 2018 - 2030 (USD Million)
Table 6 Middle East stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 7 Middle East stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 8 Middle East stem cell market, by region, 2018 - 2030 (USD Million)
Table 9 Middle East stem cell market, by country, 2018 - 2030 (USD Million)
Table 10 Middle East stem cell market, by product, 2018 - 2030 (USD Million)
Table 11 Middle East stem cell market, by application, 2018 - 2030 (USD Million)
Table 12 Middle East stem cell market, by technology, 2018 - 2030 (USD Million)
Table 13 Middle East stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 14 Middle East stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 15 Saudi Arabia stem cell market, by product, 2018 - 2030 (USD Million)
Table 16 Saudi Arabia stem cell market, by application, 2018 - 2030 (USD Million)
Table 17 Saudi Arabia stem cell market, by technology, 2018 - 2030 (USD Million)
Table 18 Saudi Arabia stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 19 Saudi Arabia stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 20 UAE stem cell market, by product, 2018 - 2030 (USD Million)
Table 21 UAE stem cell market, by application, 2018 - 2030 (USD Million)
Table 22 UAE stem cell market, by technology, 2018 - 2030 (USD Million)
Table 23 UAE stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 24 UAE stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 25 Kuwait stem cell market, by product, 2018 - 2030 (USD Million)
Table 26 Kuwait stem cell market, by application, 2018 - 2030 (USD Million)
Table 27 Kuwait stem cell market, by technology, 2018 - 2030 (USD Million)
Table 28 Kuwait stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 29 Kuwait stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 30 Israel stem cell market, by product, 2018 - 2030 (USD Million)
Table 31 Israel stem cell market, by application, 2018 - 2030 (USD Million)
Table 32 Israel stem cell market, by technology, 2018 - 2030 (USD Million)
Table 33 Israel stem cell market, by therapy, 2018 - 2030 (USD Million)
Table 34 Israel stem cell market, by end-user, 2018 - 2030 (USD Million)
Table 35 Key companies undergoing expansions
Table 36 Key companies undergoing acquisitions
Table 37 Key companies undergoing collaborations
Table 38 Key companies launching new products/services
Table 39 Key companies undertaking other strategies
List of Figures
Fig. 1 Middle East stem cell market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Middle East stem cell market driver analysis
Fig. 14 Middle East stem cell market restraint analysis
Fig. 15 Middle East stem cell market: Porter's analysis
Fig. 16 Middle East stem cell market: Product outlook and key takeaways
Fig. 17 Middle East stem cell market: Product market share analysis, 2023 - 2030
Fig. 18 Middle East stem cell by adult stem cells market, 2018 - 2030 (USD Million)
Fig. 19 Middle East stem cell market by hematopoietic market, 2018 - 2030 (USD Million)
Fig. 20 Middle East stem cell by mesenchymal market, 2018 - 2030 (USD Million)
Fig. 21 Middle East stem cell market by neural market, 2018 - 2030 (USD Million)
Fig. 22 Middle East stem cell by epithelial/skin market, 2018 - 2030 (USD Million)
Fig. 23 Middle East stem cell market by others market, 2018 - 2030 (USD Million)
Fig. 24 Middle East stem cell by human embryonic stem cells market, 2018 - 2030 (USD Million)
Fig. 25 Middle East stem cell market by induced pluripotent stem cells market, 2018 - 2030 (USD Million)
Fig. 26 Middle East stem cell by very small embryonic like stem cells market, 2018 - 2030 (USD Million)
Fig. 27 Middle East stem cell market: Application outlook and key takeaways
Fig. 28 Middle East stem cell market: Application market share analysis, 2023 - 2030
Fig. 29 Middle East stem cell by regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 30 Middle East stem cell by neurology market, 2018 - 2030 (USD Million)
Fig. 31 Middle East stem cell by orthopedics market, 2018 - 2030 (USD Million)
Fig. 32 Middle East stem cell by oncology market, 2018 - 2030 (USD Million)
Fig. 33 Middle East stem cell by hematology market, 2018 - 2030 (USD Million)
Fig. 34 Middle East stem cell by cardiovascular and myocardial infraction market, 2018 - 2030 (USD Million)
Fig. 35 Middle East stem cell by injuries market, 2018 - 2030 (USD Million)
Fig. 36 Middle East stem cell by diabetes market, 2018 - 2030 (USD Million)
Fig. 37 Middle East stem cell by liver disorder market, 2018 - 2030 (USD Million)
Fig. 38 Middle East stem cell by incontinence market, 2018 - 2030 (USD Million)
Fig. 39 Middle East stem cell by others market, 2018 - 2030 (USD Million)
Fig. 40 Middle East stem cell by drug discovery and development market, 2018 - 2030 (USD Million)
Fig. 41 Middle East stem cell market: Technology outlook and key takeaways
Fig. 42 Middle East stem cell market: Technology market share analysis, 2023 - 2030
Fig. 43 Middle East stem cell by cell acquisition market, 2018 - 2030 (USD Million)
Fig. 44 Middle East stem cell by bone marrow harvest market, 2018 - 2030 (USD Million)
Fig. 45 Middle East stem cell by umbilical blood cord market, 2018 - 2030 (USD Million)
Fig. 46 Middle East stem cell by apheresis market, 2018 - 2030 (USD Million)
Fig. 47 Middle East stem cell by cell production market, 2018 - 2030 (USD Million)
Fig. 48 Middle East stem cell by therapeutic cloning market, 2018 - 2030 (USD Million)
Fig. 49 Middle East stem cell by In-vitro fertilization market, 2018 - 2030 (USD Million)
Fig. 50 Middle East stem cell by cell culture market, 2018 - 2030 (USD Million)
Fig. 51 Middle East stem cell by isolation market, 2018 - 2030 (USD Million)
Fig. 52 Middle East stem cell by cryopreservation market, 2018 - 2030 (USD Million)
Fig. 53 Middle East stem cell by expansion and sub-culture market, 2018 - 2030 (USD Million)
Fig. 54 Middle East stem cell market: Therapy outlook and key takeaways
Fig. 55 Middle East stem cell market: Therapy market share analysis, 2023 - 2030
Fig. 56 Middle East stem cell by autologous market, 2018 - 2030 (USD Million)
Fig. 57 Middle East stem cell by allogenic market, 2018 - 2030 (USD Million)
Fig. 58 Middle East stem cell market: End-user outlook and key takeaways
Fig. 59 Middle East stem cell market: End-user market share analysis, 2023 - 2030
Fig. 60 Middle East stem cell by pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 61 Middle East stem cell by hospitals & cell banks market, 2018 - 2030 (USD Million)
Fig. 62 Middle East stem cell by academic & research institutes market, 2018 - 2030 (USD Million)
Fig. 63 Regional marketplace: Key takeaways
Fig. 64 Regional marketplace: Key takeaways
Fig. 65 Middle East stem cell market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Saudi Arabia key country dynamics
Fig. 67 Saudi Arabia stem cell market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 UAE key country dynamics
Fig. 69 UAE stem cell market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Kuwait key country dynamics
Fig. 71 Kuwait stem cell market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Israel key country dynamics
Fig. 73 Israel stem cell market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Key company categorization
Fig. 75 Company market positioning
Fig. 76 Market participant categorization
Fig. 77 Strategy framework

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • CellGenix GmbH
  • Takara Bio
  • Lonza
  • Cellartis AB
  • ATCC
  • AcceGen
  • Cell Applications, Inc.
  • Bio-Techne

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages90
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 694 Million
Forecasted Market Value ( USD ) by 2030 $ 1146.2 Million
Compound Annual Growth Rate7.5%
Regions CoveredMiddle East
No. of Companies Mentioned11

Related Topics

Related Reports

Global Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Forecast 2024-2030 - Product Image

Global Stem Cells Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells), Type (Allogeneic Stem Cell Therapy, Autologous), Therapeutic Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Human Embryonic Stem Cells Market by Type (Pluripotent Stem Cells, Totipotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering), End-User - Forecast 2024-2030 - Product Image

Global Human Embryonic Stem Cells Market by Type (Pluripotent Stem Cells, Totipotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering), End-User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Global Human Embryonic Stem Cell Market Analysis & Forecast 2024-2034: Market By Application; By End-user; and By Region - Product Image

Global Human Embryonic Stem Cell Market Analysis & Forecast 2024-2034: Market By Application; By End-user; and By Region

  • Report
  • 145 Pages
  • Global
From
Human Embryonic Stem Cell (hESC) Research: Global Strategic Business Report - Product Image

Human Embryonic Stem Cell (hESC) Research: Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.